Immunogenicity and safety of three aluminium hydroxide adjuvanted vaccines with reduced doses of inactivated polio vaccine (IPV-Al) compared with standard IPV in young infants in the Dominican Republic: a phase 2, non-inferiority, observer-blinded, randomised, and controlled dose investigation trial
Rivera, Luis, Prof, Pedersen, Rasmus S, PhD, Peña, Lourdes, MD, Olsen, Klaus J, PhD, Andreasen, Lars V, PhD, Kromann, Ingrid, BSc, Nielsen, Pernille I, MSc, Sørensen, Charlotte, MSc, Dietrich, Jes, PhD, Bandyopadhyay, Ananda S, MBBS, Thierry-Carstensen, Birgit, MSc
Published in The Lancet infectious diseases (01.07.2017)
Published in The Lancet infectious diseases (01.07.2017)
Get full text
Journal Article